Clinical Trial Update: A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1b/2a study evaluating STAR-001 (LP-184) in combination with spironolactone for supratentorial glioblastoma at firs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• STAR-001 (LP-184) (LP-184)
• Spironolactone (spironolactone)

Snippet

Sponsor: Starlight Therapeutics Inc. | Conditions: Glioblastoma (GBM) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING